Cargando…
Effect of mycophenolate mofetil dose on antibody response following initial SARS-CoV-2 vaccination in patients with systemic sclerosis
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045742/ https://www.ncbi.nlm.nih.gov/pubmed/35502180 http://dx.doi.org/10.1016/S2665-9913(22)00100-X |
_version_ | 1784695379904692224 |
---|---|
author | Wallwork, Rachel Connolly, Caoilfhionn M Shneyderman, Matthew McMahan, Zsuzsanna Mecoli, Christopher A Wigley, Fredrick Hummers, Laura K Shah, Ami A Paik, Julie J |
author_facet | Wallwork, Rachel Connolly, Caoilfhionn M Shneyderman, Matthew McMahan, Zsuzsanna Mecoli, Christopher A Wigley, Fredrick Hummers, Laura K Shah, Ami A Paik, Julie J |
author_sort | Wallwork, Rachel |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9045742 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90457422022-04-28 Effect of mycophenolate mofetil dose on antibody response following initial SARS-CoV-2 vaccination in patients with systemic sclerosis Wallwork, Rachel Connolly, Caoilfhionn M Shneyderman, Matthew McMahan, Zsuzsanna Mecoli, Christopher A Wigley, Fredrick Hummers, Laura K Shah, Ami A Paik, Julie J Lancet Rheumatol Comment Elsevier Ltd. 2022-07 2022-04-27 /pmc/articles/PMC9045742/ /pubmed/35502180 http://dx.doi.org/10.1016/S2665-9913(22)00100-X Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Comment Wallwork, Rachel Connolly, Caoilfhionn M Shneyderman, Matthew McMahan, Zsuzsanna Mecoli, Christopher A Wigley, Fredrick Hummers, Laura K Shah, Ami A Paik, Julie J Effect of mycophenolate mofetil dose on antibody response following initial SARS-CoV-2 vaccination in patients with systemic sclerosis |
title | Effect of mycophenolate mofetil dose on antibody response following initial SARS-CoV-2 vaccination in patients with systemic sclerosis |
title_full | Effect of mycophenolate mofetil dose on antibody response following initial SARS-CoV-2 vaccination in patients with systemic sclerosis |
title_fullStr | Effect of mycophenolate mofetil dose on antibody response following initial SARS-CoV-2 vaccination in patients with systemic sclerosis |
title_full_unstemmed | Effect of mycophenolate mofetil dose on antibody response following initial SARS-CoV-2 vaccination in patients with systemic sclerosis |
title_short | Effect of mycophenolate mofetil dose on antibody response following initial SARS-CoV-2 vaccination in patients with systemic sclerosis |
title_sort | effect of mycophenolate mofetil dose on antibody response following initial sars-cov-2 vaccination in patients with systemic sclerosis |
topic | Comment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045742/ https://www.ncbi.nlm.nih.gov/pubmed/35502180 http://dx.doi.org/10.1016/S2665-9913(22)00100-X |
work_keys_str_mv | AT wallworkrachel effectofmycophenolatemofetildoseonantibodyresponsefollowinginitialsarscov2vaccinationinpatientswithsystemicsclerosis AT connollycaoilfhionnm effectofmycophenolatemofetildoseonantibodyresponsefollowinginitialsarscov2vaccinationinpatientswithsystemicsclerosis AT shneydermanmatthew effectofmycophenolatemofetildoseonantibodyresponsefollowinginitialsarscov2vaccinationinpatientswithsystemicsclerosis AT mcmahanzsuzsanna effectofmycophenolatemofetildoseonantibodyresponsefollowinginitialsarscov2vaccinationinpatientswithsystemicsclerosis AT mecolichristophera effectofmycophenolatemofetildoseonantibodyresponsefollowinginitialsarscov2vaccinationinpatientswithsystemicsclerosis AT wigleyfredrick effectofmycophenolatemofetildoseonantibodyresponsefollowinginitialsarscov2vaccinationinpatientswithsystemicsclerosis AT hummerslaurak effectofmycophenolatemofetildoseonantibodyresponsefollowinginitialsarscov2vaccinationinpatientswithsystemicsclerosis AT shahamia effectofmycophenolatemofetildoseonantibodyresponsefollowinginitialsarscov2vaccinationinpatientswithsystemicsclerosis AT paikjuliej effectofmycophenolatemofetildoseonantibodyresponsefollowinginitialsarscov2vaccinationinpatientswithsystemicsclerosis |